labroots
In today's presentation I will give an overview to developing NextGen ADCs. We will discuss everything from the beginning stages of development to the varying ADC combination therapies available
Watch Now
pharmaintelligence
This webinar focuses on optimizing market access by integrating HTA and payer perspectives in development planning while preserving trial efficiency.
Watch Now
Peptide and oligonucleotide drugs are versatile therapeutics with a growing range of applications and many similarities in terms and of manufacturing and regulation.
Watch Now
quotientsciences
Many pharma companies are seeking new ways of making drug development more efficient and cost-effective through innovation, new technologies and process evolution. This has led to an increase in the outsourcing of development activities to contract research partners who focus solely on disciplines such as discovery chemistry, clinical testing, and formulation development and manufacturing.
Watch Now